Introduction of EU guideline on optimal and rational supply of medicines in public health emergency
Drug Evaluation Research
; 43(11):2158-2162, 2020.
Article
in Chinese
| CAB Abstracts | ID: covidwho-1328257
ABSTRACT
To ensure the stable supply of medicines in European Union (EU) during the coronavirus disease 2019 (COVID-19) public health emergency, EU has published Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 outbreak in April 2020. This guideline aimed to prompt EU Member States with concrete actions for the stable supply of medicines during the public health emergency. The guideline focused on the rational supply, allocation and use of medicines to treat COVID-19 patients but also covered any medicine at risk of shortage due to the pandemic. The main content of this guideline is introduced, which is expected to provide reference for perfecting the public health system of China.
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
Chinese
Journal:
Drug Evaluation Research
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS